Revision history of "HCV-ITEM: Human anti-Coronavirus vaccine that induces Specific Tecidual Immunity Multi-Epitope" (Q2867174)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2024

12 June 2023

23 May 2023

8 November 2022

29 July 2022

  • curprev 04:5804:58, 29 July 2022DG Regio talk contribs 41,481 bytes +25,090 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, nl, fr, de, it, pt, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv,

20 January 2022

17 January 2022

18 December 2021

13 December 2021

4 December 2021

21 October 2021

13 September 2021

7 July 2021

  • curprev 19:1319:13, 7 July 2021DG Regio talk contribs 9,290 bytes +431 Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string
  • curprev 01:1201:12, 7 July 2021DG Regio talk contribs 8,859 bytes +153 Changed label, description and/or aliases in en: translated_label
  • curprev 01:1201:12, 7 July 2021DG Regio talk contribs 8,706 bytes +1,146 Created claim: summary (P836): In view of the COVID-19 pandemic and consequent urgency of therapeutic solutions, the HCV-ITEM project aims to create and test the concept of an innovative vaccine, of intranasal application, capable of conferring high immunogenicity in the face of potential mutations of the virus, through the use of attenuated SARS-CoV-2., translated_summary

6 July 2021

5 July 2021